Microart Inc
Microart Inc. researches and develops innovative stem cell solutions and therapeutic applications of adult stem cells. The company develops and commercializes cell-based anti-aging research and cosmetic products. Microart Inc. also develops proprietary technology for the treatment of diabetes. The company was founded in 1980 and is based in Kowloon City, Hong Kong.
Microart Inc (MCRT) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, Microart Inc (MCRT) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Microart Inc - Net Assets Trend (None–None)
This chart illustrates how Microart Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Microart Inc (None–None)
The table below shows the annual net assets of Microart Inc from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Microart Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Microart Inc Competitors by Market Cap
The table below lists competitors of Microart Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pervasip Corp
PINK:PVSP
|
$1.86 |
|
Benchmark Energy Corporation
PINK:GPLL
|
$1.86 |
|
Lake Victoria Mining
PINK:LVCA
|
$1.87 |
|
Drug Free Solution Inc
PINK:DSOL
|
$1.87 |
|
Aquagold International Inc
PINK:AQUI
|
$1.86 |
|
California Style Palms Inc
PINK:CFPI
|
$1.86 |
|
Cambium Global Timberland Limited
PINK:CMBXF
|
$1.86 |
|
Aspyra Inc
PINK:APYI
|
$1.86 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Microart Inc's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Microart Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Microart Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Microart Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Microart Inc (MCRT) | $- | N/A | N/A | $1.86 |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |